30 Minutes. 8 Questions.
Asembia, April 28 to 30
Virtual through May 2026
Or reply directly to the person who sent you this link.
Your Research Leads
Advisory for Specialty Pharma | genflare.ai
Specialty Pharma Commercial Operations, 2026
Independent research mapping the most urgent capability gaps, AI readiness, and commercial strategy priorities across specialty pharma. Built from structured interviews with 25 to 30 senior commercial leaders.
genflare.ai | Advisory for Specialty Pharma | Findings published June 2026
The commercial model is under pressure from every direction. Not just AI. The harder questions are about where the real gaps are, why partners keep falling short, and what it takes to close the distance between aspiration and execution.
The space between commercial vision and what current infrastructure, talent, and vendors can actually deliver keeps growing.
Too slow, too generic, too theoretical. The same failure patterns repeat across consultancies, agencies, and technology vendors.
Some teams are deploying GenAI in production. Others can't get past procurement. The gap is becoming a competitive liability.
Everyone agrees these problems need solving. The question is whether there's real budget or just aspiration.
Each participant assesses the gap between where they are and where they need to be across six critical commercial functions.
This isn't a survey. It's a structured conversation designed to surface what commercial leaders actually think -- not what they'd say on a panel.
VPs and above across market access, patient services, brand, and commercial operations at specialty pharma companies.
Capability gaps, AI readiness, partner experiences, budget reality. Structured enough to quantify. Open enough for nuance.
30-minute sessions at Asembia (April 28 to 30) and virtually through May. Scheduled around you.
Anonymized and synthesized across all participants. No individual attribution. The value is in the pattern, not the source.
Your perspective shapes an industry artifact read by commercial leaders across specialty pharma. This is your voice in the conversation.
Every participant receives the complete findings before public release. Capability rankings, AI benchmarks, partner patterns, budget trends -- anonymized and unfiltered.
In your name, to a cause of your choice. A small gesture of thanks for your time and expertise.
Sessions at Asembia and virtually through May.
Or reply directly to the person who sent you this link.
Advisory for Specialty Pharma | genflare.ai